retatrutide drug retatrutide clinical trials (“reta”) is an experimental weight-loss currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works retatrutide clinical trial outcomes The

Description Amount per Serving % Daily Value Selenium (elemental)(from 5 mg L-Selenomethionine) 25 mcg 45% N-Acetyl Cysteine (NAC) 600 mg Daily Value not established

reported elevated GLP-1 levels in individuals with sarcopenia, and in vitro analyses further suggest that chronic and high exposure to GLP-1 may impair normal muscle cell differentiation and function by disrupting intracellular energy transporter (GLUT-4) translocation and mitochondrial function [88]

Endocrinology 147 , 37273736

Ozempic and Rybelsus are both approved by the US Food and Drug Administration (FDA) to treat adults with type 2 diabetes by controlling blood sugar levels